A previous report demonstrates that STING downregulation is generally observed in human lung cancer subtypes, including small-cell lung cancer, large-cell neuroendocrine lung cancer, LUAD and LUSC, in comparison to normal lung tissues [46]. The gene discussed is STING1; the disease is small cell lung carcinoma.